相关实验视频

Updated: Jul 6, 2025

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

对于抗勒沃多巴抗震主性帕金森病的脑下核和腹腔中间核进行一次性深度大脑刺激

Bin Liu^1,2, Junpeng Xu^1,2, Zhebin Feng²

¹Medical School of Chinese PLA, Beijing, China.

Frontiers in aging neuroscience

|January 8, 2024

概括

这项研究表明,下核 (STN) 和腹中核 (VIM) 的联合深度大脑刺激 (DBS) 是安全有效的,用于治疗抗乐伏多巴震主导帕金森病 (LRTD-PD). 患者在这种双重目标的DBS程序后经历了显著的症状改善.

科学领域:

神经外科神经外科
神经学神经学
运动障碍运动障碍

背景情况:

抗乐伏多巴震主导帕金森病 (LRTD-PD) 在症状管理方面提出了独特的挑战.
之前的深度大脑刺激 (DBS) 方法仅针对下丘脑核 (STN) 或全球内核 (GPi) 已经显示出控制LRTD-PD中震的局限性.
泰拉马斯的腹腔中间核 (VIM) 被认为是控制震的关键目标.

研究的目的:

评估一种新型单通组合DBS的安全性和有效性,该DBS针对LRTD-PD患者的STN和VIM.
调查LRTD-PD子组中耐火震的单轨道双目标DBS方法.

主要方法:

五名LRTD-PD患者的回顾性分析,这些患者通过跨额度方法接受了STN和VIM的一次性联合DBS.
针对VIM的指导是基于概率曲谱学.
使用统一帕金森病评分表第三部分 (UPDRS-III) 评估症状严重程度,使用39项帕金森病问卷 (PDQ-39) 评估莱沃多巴每日相当剂量 (LEDD) 和使用39项帕金森病问卷 (PDQ-39) 评估生活质量.

主要成果:

成功植入DBS导致预定义的STN和VIM目标,通过3D重建得到确认.
观察到显著的平均改善率:整体UPDRS-III的53%,震特定UPDRS项目的82.6%,PDQ-39.1的52.1%.
平均随访时间为11.4个月.

结论:

通过跨额外的方法通过STN和VIM的单通组合DBS是一种安全有效的策略,用于缓解LRTD-PD患者的症状.
这种双重目标的DBS为与LRTD-PD相关的耐火性震提供了有前途的治疗选择.

关键词:

深度大脑刺激刺激大脑莱沃多巴的反应反应亚体的细胞核.震主导的帕金森病.腹部中间核的中间核

更多相关视频

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...